Abstract
Objectives
Puberphonia or mutational falsetto (MF) is seen more in males, and hormonal changes are considered to be among the aetiological causes. Therefore, the aim of this study was to investigate the molecules [G protein-coupled oestrogen receptor 1 (GPER-1), aromatase, 17-beta-hydroxysteroid dehydrogenase (17β-HSD), cyclic adenosine monophosphate (cAMP) levels] related to receptors and pathways in patients with MF.
Methods
The study included 30 MF patients and a control group of 30 healthy individuals. Voice recordings were made of the MF patients and acoustic analyses were applied. The serum GPER-1, aromatase, 17β-HSD, cAMP levels and TSH, estradiol, prolactin, progesterone, and testosterone levels were evaluated in venous blood samples.
Results
In the MF patients, the GPER-1 level determined of mean 3.68 (1.95–4.26) pg/ml, 17 beta dehydrogenase of 5.25 (2.73–6.77) ng/ml, and cAMP of 24.62 (11.62–30.35) ng/ml were statistically signficantly higher than those of the control group (p = 0.008, p = 0.002, p = 0.003, respectively). The aromatase level in the MF patients was found to be 3.48 (2.01–4.91) and the difference between the two groups was not statistically significant (p = 0.067).
Conclusion
The GPER-1, 17β-HSD, and cAMP levels were found to be higher in the MF patients than in the control group, suggesting that they could be of importance in the diagnosis and treatment of MF.
Similar content being viewed by others
References
Hammarberg B (1987) Pitch and quality characteristics of mutational voice disorders before and after therapy. Folia Phoniatr (Basel) 39:204–216
Hacki T, Heitmüller S (1999) Development of the child's voice: premutation, mutation. Int J Pediatr Otorhinolaryngol 49:141–144
Filardo EJ, Quinn JA, Bland KI, Frackelton AR Jr (2000) Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB–EGF. Mol Endocrinol 14:1649–1660
Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER (2005) A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307:1625–1630
Filardo EJ, Quinn JA, Frackelton AR Jr, Bland KI (2002) Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol 16:70–84
Beaudoin C, Bonenfant M, Tremblay Y (1997) Regulation of cytochrome P450 cholesterol side-chain cleavage, 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase type 1 and estradiol-17 beta-hydroxysteroid dehydrogenase mRNA levels by calcium in human choriocarcinoma JEG-3 cells. Mol Cell Endocrinol 133:63–71
Carreau S, Bourguiba S, Lambard S et al (2002) Reproductive system: aromatase and estrogens. Mol Cell Endocrinol 193:137–143
Carreau S, de Vienne C, Galeraud-Denis I (2008) Aromatase and estrogens in man reproduction: a review and latest advances. Adv Med Sci 53:139–144
Carpino A, Romeo F, Rago V (2004) Aromatase immunolocalization in human ductuli efferentes and proximal ductus epididymis. J Anat 204:217–220
Pereyra-Martinez AC, Roselli CE, Stadelman HL, Resko JA (2001) Cytochrome P450 aromatase in testis and epididymis of male rhesus monkeys. Endocrine 16:15–19
Kilic MA, Okur E, Yildirim I et al (2008) Turkish version of the voice handicap index. Kulak Burun Bogaz Ihtis Derg 18:139–147
Garcia-Segura LM, Balthazart J (2009) Steroids and neuroprotection: new advances. Front Neuroendocrinol 30(2):v–i. https://doi.org/10.1016/j.yfrne.2009.04.006
Findikli E, Kurutas EB, Camkurt MA et al (2017) Increased serum G protein-coupled estrogen receptor 1 levels and its diagnostic value in drug naïve patients with major depressive disorder. Clin Psychopharmacol Neurosci 15:337–342
Orhan FÖ, Kurutaş EB, Doğaner A et al (2018) Serum levels of GPER-1 in euthymic bipolar patients. Neuropsychiatr Dis Treat 26:855–862
Bilal N, Kurutas EB, Orhan I (2018) An evaluation of G-protein coupled membrane estrogen receptor-1 level in stuttering. Eur Arch Otorhinolaryngol 275:469–476
Colton RY, Casper JK, Leonard R. Undestanding voice problems. puberfonia. In: Differantial diagnosis of voice problems. 4thEd. Williams and Wilkins, Baltimore, 2011, pp 11–62.
Patel VH, Chen J, Ramanjaneya M et al (2010) G-protein coupled estrogen receptor 1 expression in rat and human heart: protective role during ischaemic stress. Int J Mol Med 26:193–199
Recchia AG, De Francesco EM, Vivacqua A et al (2011) The G protein-coupled receptor 30 is up-regulated by hypoxia-inducible factor-1alpha (HIF-1alpha) in breast cancer cells and cardiomyocytes. J Biol Chem 286:10773–10782
Martensson UE, Salehi SA, Windahl S et al (2009) Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice. Endocrinology 150:687–698
Filardo EJ, Graeber CT, Quinn JA et al (2006) Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression. Clin Cancer Res 12:6359–6366
Smith HO, Leslie KK, Singh M et al (2007) GPR30: a novel indicator of poor survival for endometrial carcinoma. Am J Obstet Gynecol 196:386.e1–11
Smith HO, Arias-Pulido H, Kuo DY et al (2009) GPR30 predicts poor survival for ovarian cancer. Gynecol Oncol 114:465–471
McNamara KM, Sasano H (2018) The role of 17βHSDs in breast tissue and breast cancers. Mol Cell Endocrinol S0303–7207:30314–30319
Sanderson JT (2006) The steroid hormone biosynthesis pathway as a target for endocrine-disrupting chemicals. Toxicol Sci 94:3–21
Qu JH, Hong X, Chen JF et al (2008) Fenvalerate inhibits progesterone production through cAMP-dependent signal pathway. Toxicol Lett 176:31–39
Kim Y, Ryu JC, Choi HS, Lee K (2011) Effect of 2,2′,4,4′-tetra hydroxy benzophenone (BP2) on steroidogenesis in testicular Leydig cells. Toxicology 288:18–26
Ronco AM, Valdes K, Marcus D, Llanos M (2001) The mechanism for lindane-induced inhibition of steroidogenesis in cultured rat Leydig cells. Toxicology 159:99–106
Fuchs M, Fröehlich M, Bettina Hentschel B, Eberhard Kruse E, Knauft D (2007) Predicting mutational change in the speaking voice of boys. J Voice 21:169–178
Behlau M, Azevedo R, Pontes P (2001) Desenvolvimento da laringe. In: Behlau M (ed) Voz: o livro do especialista, vol 1. Revinter, Rio de Janeiro, pp 53–56
Laukkanen A-M, Titze IR, Finnegan EM, Hoffman H (2002) Laryngeal muscle activity in a tonal scale: comparing speech-like to song-like productions in a mezzo-soprano. J Singing 59:49–56
Kitajima Y, Ono Y (2016) Estrogens maintain skeletal muscle and satellite cell functions. J Endocrinol 229:267–275
Acknowledgements
This study was presented in 11th National Laryngology Congress.
Funding
This study was supported financially by the Kahramanmaras Sutcu Imam University Scientific research Project unit (Project no. 2018/2-47 M).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of ınterest
The authors have no conflict of interests to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sagiroglu, S., Kılınc, M., Doganer, A. et al. G protein coupled oestrogen receptor 1, aromatase, 17β-HSD and cAMP level in mutational falsetto. Eur Arch Otorhinolaryngol 277, 1121–1127 (2020). https://doi.org/10.1007/s00405-020-05795-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-020-05795-1